Central AsianResearch Index

THE TRANSCRIPTOME PROFILE OF PATIENTS WITH SEVERE PSORIASIS

ТРАСКРИПТОМНЫЙ ПРОФИЛЬ БОЛЬНЫХ ТЯЖЁЛЫМ ПСОРИАЗОМ

In current dermatological practice, there is an increasing prevalence of patients with severe psoriasis who are resistant to methotrexate (MTX) therapy. Objective: This study aimed to identify differentially expressed genes in the skin of psoriasis patients with MTX resistance using transcriptome profiling to evaluate the molecular basis of treatment efficacy. Methods: The study included 6 patients with widespread psoriasis vulgaris receiving MTX (7.5-25 mg/week) combined with folic acid (5 mg/week). Patients were categorized into two groups based on their 6-month clinical response: responders and non-responders. A control group consisted of patients with widespread psoriasis who were MTX-naïve. Skin biopsies were collected from lesional skin, preserved in RNA-stabilizing solution, and processed for total RNA extraction. Results: Genetic analysis identified key molecular markers associated with chronic inflammatory disease progression and the development of drug resistance. Conclusion: Individual transcriptomic profiling in patients with severe psoriasis may facilitate the development of personalized therapeutic approaches. Keywords: Psoriasis, methotrexate, transcriptome profile, resistance, total RNA.

Сведения

Журнал
Avicenna Bulletin
Опубликовано
2026 · Т. 28, № 1, С. 190-205
Язык
Английский
ISSN
2074-0581 · 2959-6327
Издатель
Avicenna Tajik State Medical University
Аффилиации
Krasnoyarsk State Medical University named after Professor V.F. Voino-Yasenetsky, Krasnoyarsk, Russian Federation
Laboratory of Genomic Research and Biotechnology, Krasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Sciences, Krasnoyarsk, Russian Federation